Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience

Introduction: To evaluate the effectiveness and safety of intravitreal dexamethasone (DEX) implants in refractory diabetic macular edema (DME) treated by intravitreal ranibizumab. Materials and Methods: We retrospectively analyzed DME patients who received DEX implant treatment after being refractor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsia, Ning-Yi, Lin, Chun-Ju, Chen, Huan-Sheng, Chang, Cheng-Hsien, Bair, Henry, Lai, Chun-Ting, Lin, Jane-Ming, Chen, Wen-Lu, Tien, Peng-Tai, Wu, Wen-Chuan, Tsai, Yi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121145/
https://www.ncbi.nlm.nih.gov/pubmed/33996856
http://dx.doi.org/10.3389/fmed.2021.649979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121145/
https://www.ncbi.nlm.nih.gov/pubmed/33996856
http://dx.doi.org/10.3389/fmed.2021.649979

Ejemplares similares